In our study, we sought to identify novel histone modifiers presenting a dual function of inducing histone acetylation and, therefore, sensitizing tumor cells to chemotherapy and reducing Snail levels from ACC cells. The gene discussed is SNAI1; the disease is adrenal cortex carcinoma.